Further, we also demonstrated that this estrogen-mediated protection against the pMCAO-induced autonomic dysfunction was estrogen receptor dependent, as the effect was blocked by the prior or concomitant administration of the selective estrogen receptor antagonist, ICI-182,780 [4]. This evidence concerns the gene ESR1 and Abnormal autonomic nervous system physiology.